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Background:  The efficacy of intravenous immunoglobulin (IVIG) treatment for patients with Kawasaki disease (KD) within 9 days of illness was 
confirmed. However, there were few reports regarding those after 10 days of illness. The purposes of this study were to investigate the efficacy of the 
IVIG treatment after 10 days of illness.
Methods:  The database of 20th nationwide survey of KD (subjects of this survey were patients who were admitted from January 2007 to December 
2008) in Japan was used. We selected patients as who were treated with initial IVIG from 10 to 20 days of illness. Then we selected matched-pair 
control as who was same sex, age, treated with initial IVIG from 4 to 8 days of illness with same dose, and reported from the same institutions. We 
compared the characteristics, coronary status, and fractional change (FC) of various laboratory data before and after IVIG treatment. FC was defined 
as follows: FC=(Y-X)/X in which X represents data before IVIG and Y represents data after IVIG.
Results:  A total of 124 patients were selected. Among 124 patients, a total of 50 patients were excluded because mistake reports (11 patients), 
and not available suitable data (39 patients). Therefore, a total of 74 pairs were studied. The proportion of incomplete KD in patients were higher 
than that in controls (51% vs. 18, p<.001). The proportion of patients who were treated with additional treatment was similar between the groups 
(12% vs. 15%). The FC of white blood cell count (-0.18 vs. -0.39), the percentage of neutrophil (-0.37 vs. -0.42), and C-reactive protein (-0.50 vs. 
-0.53) were also similar. Among 34 pairs who did not notice the coronary change before initial IVIG treatment, there were no significant differences 
of cardiovascular abnormalities within 1 month (15% vs. 12%) and after 1 month (6% vs. 0%). The cardiovascular abnormalities after 1 month in 
patients were all dilation of coronary artery, not aneurysm.
Conclusion: The efficacy of IVIG treatment for patients with KD after 10 days of illness is equivalent to those within 9 days of illness.
